News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
147 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17884)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
CareDx Reports Third Quarter 2017 Financial Results
Achieved total revenue for the third quarter of 2017 of $12.2 million.
November 10, 2017
·
13 min read
Business
ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update
Cash, cash equivalents and marketable securities totaled $16.0 million as of September 30, 2017, compared to $23.5 million as of December 31, 2016.
November 10, 2017
·
7 min read
Business
Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results
Dova reported a net loss of $9.7 million for the third quarter of 2017, compared to a net loss of $7.2 million for the same period in 2016.
November 10, 2017
·
6 min read
Business
Neovasc Inc. to Host Third Quarter 2017 Conference Call
The Company will subsequently hold a conference call that same day at 4:30 pm Eastern Time hosted by Mr. Alexei Marko, CEO, and Mr. Chris Clark, CFO.
November 10, 2017
·
1 min read
Drug Development
Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in Both Phase II Clinical Trials in Postpartum Depression
Brexanolone achieved the primary endpoint in both trials, a mean reduction from baseline in the Hamilton Rating Scale for Depression total score compared to placebo at 60 hours.
November 10, 2017
·
13 min read
BioMidwest
Washington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System From ViewRay
This marks the hospital’s second MRIdian system, furthering their leadership role in the delivery of MR-guided radiation therapy.
November 10, 2017
·
3 min read
American Academy of Ophthalmology Release: Genetic Treatment for Blindness May Soon be Reality
Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
November 10, 2017
·
2 min read
Business
CheckedUp Expands 3D and AI Capabilities Through Licensing Deal
CheckedUp announced that it has licensed 3D imaging technologies from Cirle, a medical technology incubator, for use in its patient engagement platform.
November 10, 2017
·
3 min read
Neovasc Announces $65M Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and Warrants
The price of $1.46 per Unit represents the market price of Neovasc’s common shares as of the date of this news release.
November 10, 2017
·
24 min read
Getinge Sets Revised Strategy, New Financial Targets Ahead of Arjo Listing
Focus is on organic growth and Getinge foresees an organic market growth of 2-4% on average during 2017-2020 in the addressable market.
November 10, 2017
·
21 min read
Previous
11 of 15
Next